| Literature DB >> 34292429 |
Ashley Chory1, Grant Callen2, Winstone Nyandiko3,4,5, Tabitha Njoroge3, Celestine Ashimosi3, Josephine Aluoch3, Michael Scanlon1, Carole McAteer3, Edith Apondi3, Rachel Vreeman6,7.
Abstract
Mobile technologies represent potentially novel and scalable intervention delivery platforms for adolescents living with HIV (ALWH) in low- and middle-income countries. We conducted a prospective, mixed methods pilot study to evaluate the acceptability and feasibility of the WhatsApp® platform to deliver individual counseling services and facilitate peer support for ALWH in western Kenya. Thirty ALWH (17 female, mean age 15.4) on ART, engaged in HIV care and aware of their status, were enrolled. After 6 months, participants described their experiences with the intervention. Treatment adherence, stigma, and mental and behavioral health were assessed prospectively. Participants reported overall positive experiences and indicated that the platform encouraged peer network development. They endorsed potential benefits for treatment adherence, stigma reduction, and mental and behavioral health. All participants supported intervention expansion. In western Kenya, WhatsApp® was an acceptable and feasible platform for mobile counseling and peer support for ALWH.Entities:
Keywords: Adolescents; HIV; Kenya; WhatsApp; mHealth
Mesh:
Year: 2021 PMID: 34292429 PMCID: PMC8295454 DOI: 10.1007/s10461-021-03376-9
Source DB: PubMed Journal: AIDS Behav ISSN: 1090-7165
Benefits and challenges to using WhatsApp® among ALWH
| Theme | Illustrative quotes |
|---|---|
| Facilitation of relationships and communication | ‘The group was good because it helped us have friends because I used to think I was alone, when I came to the clinic I did not have friends, but from that group, I got friends where we would talk and encourage each other, and in the WhatsApp, everybody was allowed to give their views’ ‘I was happy to be in the group, I learnt that I am not the only one who is positive because I used to be stressed a lot before I knew that we were many’ |
| Access to a counselor | ‘We talked about health issues, and hygiene and also asking about viral load’ ‘I was very stressed and bored with lif,e and I needed to talk to someone privately not in the group and it helped me feel good’ |
| Medication adherence | ‘It helped me by reminding me to take medicine… My friends would call to remind me to take medicine’ ‘The group was very educational, I liked it most that I have learnt about the right way to take the medicine’ |
| Barriers to involvement | ‘Sometimes, I would have a lot of work to do at home and homework and by the time I finished, it was already past 10 pm which would make me miss participating in the group’ ‘Most of the time, my phone would refuse to function, and this was the major challenge because I would go offline until it is serviced. Sometimes, my phone would spoil and sometimes not have power. This would make me be left behind and catching up on where I had left was a challenge’ ‘My parents used to keep the phone, and I would use it over the weekends’ |
| Chat dynamics | ‘It was good to put them [boys and girls] together so that we chat together and if there was something, they needed to discuss separately they can send in a private message’ ‘[I preferred] The group because, when you are two you don’t get a lot of ideas but in the group most people would come with different ideas which would be helpful’ |
| Integrating WhatsApp counseling into routine care | ‘Yes [you should expand the platform] because, patients in every clinic will learn that they are not alone and [participation in the group] would help in suppressing the virus’ ‘There are so many things that people don’t know and [Participation in the group] will help them learn’ |
Mental and behavioral health outcomes
| N (%) | At initial evaluation (n = 30) | 3-month follow-up (n = 29) | 6-month follow-up (n = 29) |
|---|---|---|---|
| PHQ | |||
| None | 29 (96.7) | 29 (100) | 28 (96.6) |
| Mild | 1 (3.3) | 0 (0) | 1 (3.5) |
| SDQ total difficulties | 12.70 (3.51) | 12.57 (2.39) | 13.83 (2.61) |
| SDQ difficulties category | |||
| Normal | 25 (83.3) | 25 (86.2) | 23 (79.3) |
| Borderline | 3 (10.0) | 4 (13.8) | 6 (20.7) |
| Abnormal | 2 (6.7) | 0 (0) | 0 (0) |
| Hopkins anxiety | |||
| Normal | 28 (93.3) | 29 (100) | 29 (100) |
| Symptomatic | 2 (6.7) | 0 (0) | 0 (0) |
| Hopkins depression | |||
| Normal | 29 (96.7) | 29 (100) | 28 (96.6) |
| Symptomatic | 1 (3.3) | 0 (0) | 1 (3.5) |
| Hopkins total | |||
| Normal | 29 (96.7) | 29 (100) | 29 (100) |
| Symptomatic | 1 (3.3) | 0 (0) | 0 (0) |
HIV stigma outcomes
| N (%) | At initial evaluation (n = 30) | 3-month follow-up (n = 29) | 6-month follow-up (n = 29) |
|---|---|---|---|
| I have lost friends | 1 (3.3) | 0 (0) | 1 (3.5) |
| Called names/bullied | 3 (10.0) | 0 (0) | 2 (6.9) |
| Discrimination at home | 4 (13.3) | 0 (0) | 2 (6.9) |
| Discrimination neighbor | 1 (3.3) | 0 (0) | 0 (0) |
| Discrimination church | 0 (0) | 0 (0) | 0 (0) |
| Discrimination clinic | 0 (0) | 0 (0) | 0 (0) |
| Stigma at school | 1 (3.3) | 0 (0) | 1 (3.5) |
| Discrimination other | 0 (0) | 0 (0) | 1 (3.5) |
| Loss of financial | 0 (0) | 0 (0) | 0 (0) |
| Loss of social | 0 (0) | 0 (0) | 0 (0) |
| Feel stressed/anxious | 3 (10.0) | 0 (0) | 6 (20.7) |
| Feel depressed/sad | 3 (10.0) | 0 (0) | 7 (24.1) |
| Don’t play/go places | 1 (3.3) | 1 (3.5) | 1 (3.5) |
| Important keep secret | 19 (63.3) | 16 (55.2) | 22 (75.9) |
| CG keeps secret | 17 (58.6) | 16 (55.2) | 21 (72.4) |
| Future changed negative | 5 (16.7) | 1 (3.6) | 3 (10.3) |
| Missed meds so people don’t see | 5 (16.7) | 2 (6.9) | 6 (20.7) |
| Community thinks HIV dirty/shameful/immoral disease | |||
| No one thinks that | 23 (76.7) | 20 (69.0) | 14 (48.3) |
| A few people | 4 (13.3) | 9 (31.0) | 14 (48.3) |
| Most | 3 (10.0) | 0 (0) | 1 (3.5) |
Adherence outcomes
| Baseline (N = 30) | 3-month (N = 29) | 6-month (N = 29) | |
|---|---|---|---|
| CAMP Adherence Questionnaire | |||
| Responsible for his/her own medication taking | 30 (100) | 29 (100) | 28 (96.6) |
| Reported problems taking medication on time | 4 (13.3) | 0 (0) | 3 (10.3) |
| Reported missed doses in past 7 days | |||
| 0 | 25 (83.3) | 28 (96.6) | 26 (89.7) |
| 1 | 4 (13.3) | 1 (3.5) | 0 (0) |
| 2 | 1 (3.3) | 0 (0) | 2 (6.9) |
| 3 | 0 (0) | 0 (0) | 1 (3.5) |
| Reported doses taken more than 1 h late in past 7 days | |||
| 0 | 22 (73.3) | 26 (89.7) | 27 (93.1) |
| 1 | 5 (16.7) | 2 (6.9) | 0 (0) |
| 2 | 2 (6.7) | 1 (3.5) | 0 (0) |
| 3 | 1 (3.3) | 0 (0) | 1 (3.5) |
| 6 | 0 (0) | 0 (0) | 1 (3.5) |
| Reported missed doses in past 30 days | |||
| 0 | 21 (75.0) | 27 (100) | 28 (96.6) |
| 1 | 2 (7.1) | 0 (0) | 0 (0) |
| 2 | 2 (7.1) | 0 (0) | 0 (0) |
| 3 | 2 (7.1) | 0 (0) | 0 (0) |
| 6 | 1 (3.6) | 0 (0) | 0 (0) |
| 8 | 0 (0) | 0 (0) | 1 (3.5) |
| Number of people in household taking HIV medication (including respondent) | |||
| 1 | 9 (30.0) | 9 (31.0) | 7 (25.0) |
| 2 | 14 (46.7) | 15 (51.7) | 14 (50.0) |
| 3 | 7 (23.3) | 5 (17.2) | 7 (25.0) |
| MEMS electronic dose monitoring adherence | |||
| MEMS % of doses taken, mean (mean, SD) | 78.2 (24) | ||
| MEMS adherent > 90%, frequency (n, %) | 17 (59%) | ||
| 1 or more MEMS treatment interruptions > 48 h (n, %) | 18 (62%) | ||